Lieff Cabraser Civil Justice Blog
Elizabeth Cabraser Inducted Into National Trial Lawyers Association Trial Lawyer Hall of Fame

Elizabeth Cabraser Inducted Into National Trial Lawyers Association Trial Lawyer Hall of Fame

Lieff Cabraser founding partner Elizabeth J. Cabraser has been inducted into the National Trial Lawyers Association Trial Lawyer Hall of Fame. “Each year, the Trial Lawyer Hall of Fame recognizes and honors these remarkable individuals, both past and present, who have left an indelible mark on the American legal tradition through a lifetime of service to the American public, the Constitution, and the American trial bar.”

As noted by the Trial Lawyer Hall of Fame, “Throughout American history, exceptional trial lawyers have exceeded the expectations of the public and their peers by clearly establishing themselves, through their practice, as true champions and crusaders for American justice. To honor these legendary trial lawyers, the National Trial Lawyers Association established the Trial Lawyer Hall of Fame.”

The induction ceremony will take place at Mass Torts Made Perfect – the ceremony will be held Thursday, April 12, 2018, at the Wynn Hotel in Las Vegas.

Congratulations Elizabeth on this wonderful accomplishment!

About Elizabeth Cabraser

A name partner and co-founder of Lieff Cabraser, Elizabeth Cabraser chairs the firm’s personal injury and environmental litigation practice groups. One of the nation’s leading class action litigators and possessing unparalleled expertise in complex civil litigation, she has served as court-appointed lead, co-lead, or class counsel in scores of federal multi-district and state coordinated proceedings. Today, she serves in court-appointed leadership positions in several of the nation’s highest profile civil cases, including a solo leadership role in the VW “Clean Diesel” Emissions case, as well as lead positions in the GM ignition switch defect and Takata defective airbag cases, and the recently-filed Fiat Chrysler Jeep Dodge diesel emissions fraud litigation, Generic Drugs Pricing antitrust litigation, and the National Prescription Opiates litigation.